Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 135

1.

H19 Is Expressed in Hybrid Hepatocyte Nuclear Factor 4α+ Periportal Hepatocytes but Not Cytokeratin 19+ Cholangiocytes in Cholestatic Livers.

Jiang Y, Huang Y, Cai S, Song Y, Boyer JL, Zhang K, Gao L, Zhao J, Huang W, Liang G, Liangpunsakul S, Wang L.

Hepatol Commun. 2018 Sep 24;2(11):1356-1368. doi: 10.1002/hep4.1252. eCollection 2018 Nov.

2.

Lipid mediators of liver injury in nonalcoholic fatty liver disease.

Liangpunsakul S, Chalasani N.

Am J Physiol Gastrointest Liver Physiol. 2018 Nov 1. doi: 10.1152/ajpgi.00170.2018. [Epub ahead of print]

PMID:
30383414
3.

EUS-guided fine needle injection is superior to direct endoscopic injection of 2-octyl cyanoacrylate for the treatment of gastric variceal bleeding.

Bick BL, Al-Haddad M, Liangpunsakul S, Ghabril MS, DeWitt JM.

Surg Endosc. 2018 Sep 26. doi: 10.1007/s00464-018-6462-z. [Epub ahead of print]

PMID:
30259158
4.

Levels of circulating follicular helper T cells, T helper 1 cells, and the prognostic significance of soluble form of CD40 ligand on survival in patients with alcoholic cirrhosis.

Hollister K, Kusumanchi P, Ross RA, Chandler K, Oshodi A, Heathers L, Teagarden S, Wang L, Dent AL, Liangpunsakul S.

Liver Res. 2018 Mar;2(1):52-59. doi: 10.1016/j.livres.2018.02.001. Epub 2018 Feb 22.

PMID:
30221017
5.

Posttraumatic Stress Disorder in Patients with Heavy Alcohol Consumption and Alcoholic Hepatitis.

Samala N, Lourens SG, Shah VH, Kamath PS, Sanyal AJ, Crabb DW, Tang Q, Radaeva S, Liangpunsakul S, Chalasani N.

Alcohol Clin Exp Res. 2018 Oct;42(10):1933-1938. doi: 10.1111/acer.13862. Epub 2018 Aug 26.

PMID:
30080255
6.

MicroRNA-26-5p functions as a new inhibitor of hepatoblastoma by repressing lin-28 homolog B and aurora kinase a expression.

Zhang Y, Zhao Y, Wu J, Liangpunsakul S, Niu J, Wang L.

Hepatol Commun. 2018 May 21;2(7):861-871. doi: 10.1002/hep4.1185. eCollection 2018 Jul.

7.

Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development.

Lubecka K, Flower K, Beetch M, Qiu J, Kurzava L, Buvala H, Ruhayel A, Gawrieh S, Liangpunsakul S, Gonzalez T, McCabe G, Chalasani N, Flanagan JM, Stefanska B.

Epigenetics. 2018;13(6):605-626. doi: 10.1080/15592294.2018.1481706. Epub 2018 Jul 30.

PMID:
29927686
8.

Association Between Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism and Alcoholic Liver Disease.

Chang B, Hao S, Zhang L, Gao M, Sun Y, Huang A, Teng G, Li B, Crabb DW, Kusumanchi P, Wang L, Liangpunsakul S, Zou Z.

Am J Med Sci. 2018 Jul;356(1):10-14. doi: 10.1016/j.amjms.2018.03.012. Epub 2018 Mar 20.

PMID:
29779728
9.

Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?

Sandrasegaran K, Cui E, Elkady R, Gasparis P, Borthakur G, Tann M, Liangpunsakul S.

Eur Radiol. 2018 Oct;28(10):4215-4224. doi: 10.1007/s00330-018-5366-6. Epub 2018 Apr 12.

PMID:
29651764
10.

Long Non-coding RNA in Liver Metabolism and Disease: Current Status.

Zhao Y, Wu J, Liangpunsakul S, Wang L.

Liver Res. 2017 Sep;1(3):163-167. doi: 10.1016/j.livres.2017.09.001. Epub 2017 Dec 2.

11.

Early activation of peripheral monocytes with hallmarks of M1 and M2 monocytic cells in excessive alcohol drinkers: a pilot study.

Walline CC, Blum JS, Linton T, Mangiacarne D, Liangpunsakul S.

J Investig Med. 2018 Jun;66(5):1-4. doi: 10.1136/jim-2017-000706. Epub 2018 Mar 8.

PMID:
29519798
12.

Interaction between the patatin-like phospholipase domain-containing protein 3 genotype and coffee drinking and the risk for acute alcoholic hepatitis.

Liangpunsakul S, Beaudoin JJ, Shah VH, Puri P, Sanyal AJ, Kamath PS, Lourens SG, Tang Q, Katz BP, Crabb DW, Chalasani NP.

Hepatol Commun. 2017 Nov 11;2(1):29-34. doi: 10.1002/hep4.1123. eCollection 2018 Jan.

13.

Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis.

Whitfield JB, Masson S, Liangpunsakul S, Hyman J, Mueller S, Aithal G, Eyer F, Gleeson D, Thompson A, Stickel F, Soyka M, Daly AK, Cordell HJ, Liang T, Foroud T, Lumeng L, Pirmohamed M, Nalpas B, Bence C, Jacquet JM, Louvet A, Moirand R, Nahon P, Naveau S, Perney P, Podevin P, Haber PS, Seitz HK, Day CP, Mathurin P, Morgan TM, Seth D; GenomALC Consortium.

Alcohol. 2018 Feb;66:1-7. doi: 10.1016/j.alcohol.2017.07.006. Epub 2017 Sep 23.

PMID:
29277282
14.

Concomitant Psychiatric and Nonalcohol-Related Substance Use Disorders Among Hospitalized Patients with Alcoholic Liver Disease in the United States.

Jinjuvadia R, Jinjuvadia C, Puangsricharoen P, Chalasani N, Crabb DW, Liangpunsakul S; Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium.

Alcohol Clin Exp Res. 2018 Feb;42(2):397-402. doi: 10.1111/acer.13567. Epub 2018 Jan 1.

PMID:
29197092
15.

LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosis.

Yang Z, Ross RA, Zhao S, Tu W, Liangpunsakul S, Wang L.

Hepatol Commun. 2017 Aug;1(6):513-523. doi: 10.1002/hep4.1061. Epub 2017 Aug 2.

16.

The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis.

Puri P, Liangpunsakul S, Christensen JE, Shah VH, Kamath PS, Gores GJ, Walker S, Comerford M, Katz B, Borst A, Yu Q, Kumar DP, Mirshahi F, Radaeva S, Chalasani NP, Crabb DW, Sanyal AJ; TREAT Consortium.

Hepatology. 2018 Apr;67(4):1284-1302. doi: 10.1002/hep.29623. Epub 2018 Feb 22.

17.

Hepatocellular Carcinoma: A Decade of Hospitalizations and Financial Burden in the United States.

Jinjuvadia R, Salami A, Lenhart A, Jinjuvadia K, Liangpunsakul S, Salgia R.

Am J Med Sci. 2017 Oct;354(4):362-369. doi: 10.1016/j.amjms.2017.05.016. Epub 2017 Jun 1.

18.

Challenges in Patient Enrollment and Retention in Clinical Studies for Alcoholic Hepatitis: Experience of the TREAT Consortium.

Comerford M, Lourens S, Liangpunsakul S, Chalasani NP, Sanyal AJ, Shah VH, Kamath PS, Puri P, Katz BP, Radaeva S, Crabb DW.

Alcohol Clin Exp Res. 2017 Dec;41(12):2000-2006. doi: 10.1111/acer.13515. Epub 2017 Oct 27. Review.

PMID:
28981151
19.

IL-1 receptor like 1 protects against alcoholic liver injury by limiting NF-κB activation in hepatic macrophages.

Wang M, Shen G, Xu L, Liu X, Brown JM, Feng D, Ross RA, Gao B, Liangpunsakul S, Ju C.

J Hepatol. 2017 Sep 21. pii: S0168-8278(17)32263-8. doi: 10.1016/j.jhep.2017.08.023. [Epub ahead of print]

PMID:
28870670
20.

Supplemental Content

Loading ...
Support Center